Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03275389 |
|---|---|
| Brief Title: | A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years |
| First Submitted : | August 29, 2017 |
| First Submitted that Met QC Criteria : | September 5, 2017 |
| First Posted : | September 7, 2017 |
| Results First Submitted : | March 16, 2021 |
| Results First Submitted that Met QC Criteria : | April 14, 2021 |
| Results First Posted : | May 7, 2021 |
| Last Update Submitted that Met QC Criteria : | April 14, 2021 |
| Last Update Posted : | May 7, 2021 |